Kiverdi is a technology company.
Kiverdi has raised $500K across 1 funding round.
Kiverdi has raised $500K in total across 1 funding round.
Kiverdi has raised $500K in total across 1 funding round.
Kiverdi's investors include Ehukai Investments.
Kiverdi is a biotechnology company that develops carbon transformation technologies to convert carbon dioxide (CO2) into sustainable bio-based products, targeting environmental, agricultural, and food sectors.[1][2][3][4] It serves industries adopting circular economy principles, such as sustainable supply chains for biodegradable goods, soil nutrients, marine feed, proteins, and pet food, solving problems like resource depletion, food security, climate change, price volatility, land/water overuse, and reliance on fossil fuels or food crops.[1][2][3][4] Founded in 2011 and headquartered in Pleasanton, California, Kiverdi uses NASA-inspired microbial fermentation processes that require far less land and water than traditional methods, with over 50 patents granted or pending and reported revenue around $7.3 million.[1][3][4] Growth momentum includes partnerships like with P&G for net-zero supply chains and high-profile visibility through TED talks and NOVA documentaries by CEO Dr. Lisa Dyson.[1][5]
Kiverdi was founded in 2011 in Pleasanton, California, by a team of scientists, engineers, and business leaders committed to sustainable production amid global resource challenges from population growth.[1][3][4] CEO Dr. Lisa Dyson, a key figure, has driven the vision, appearing on TED stages and in NOVA's "Decoding The Weather Machine" to advocate for carbon recycling, with early inspiration from NASA's concepts for using microorganisms to convert CO2 into usable materials.[3][5] The idea emerged from recognizing flaws in extractive supply chains, leading to a biotech platform that repurposes abundant CO2—36 billion tons emitted annually—into nutrients and products, bridging sustainability and profitability without diverting food crops.[2][3][4] Pivotal early traction came from developing AIR PROTEIN and commercial solutions, evolving from lab innovations to industry partnerships like P&G's CO2-Tech initiative aligned with EU environmental goals.[1][3]
Kiverdi stands out in biotech through these key strengths:
Kiverdi rides the wave of carbon utilization and circular economy trends, capitalizing on global pressures to cut 36 billion tons of annual CO2 emissions while meeting rising demand for sustainable food, agriculture, and materials amid climate change and resource scarcity.[2][3] Timing is ideal with EU sustainability mandates, corporate net-zero pledges (e.g., P&G partnership), and biotech advances in fermentation, positioning Kiverdi to disrupt extractive industries like traditional farming and fossil-based manufacturing that strain land, water, and food supplies.[1][2][4] Market forces favoring it include investor interest in climate tech, regulatory incentives for low-carbon products, and consumer shifts toward eco-friendly alternatives, amplified by its efficient, scalable model that integrates with existing infrastructure like greenhouses.[3][4] By commercializing CO2 as a resource, Kiverdi influences the ecosystem, inspiring similar innovations and accelerating the shift to resilient, planet-positive production systems.[2]
Kiverdi is poised to scale its carbon transformation platform through expanded commercial pilots, like AIR PROTEIN and P&G collaborations, targeting food security and net-zero supply chains in a world facing escalating climate pressures.[1][5] Trends like advancing synthetic biology, carbon pricing, and precision fermentation will propel growth, potentially unlocking billion-dollar markets in sustainable proteins and materials as partnerships deepen and patents mature.[3] Its influence may evolve from niche innovator to ecosystem shaper, powering a circular economy that turns planetary liabilities like CO2 into profitable assets—remaking how everyday products sustain both business and the planet, as its mission promises.[2][3]
Kiverdi has raised $500K across 1 funding round. Most recently, it raised $500K Seed in January 2014.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2014 | $500K Seed | Ehukai Investments |